NO20084353L - Krystallinske former av N-{2-tert-butyl-1-[(4,4-difluorcykloheksyl)metyl]-1H-benzimidazol-5-yl} etansulfonamidsalter - Google Patents
Krystallinske former av N-{2-tert-butyl-1-[(4,4-difluorcykloheksyl)metyl]-1H-benzimidazol-5-yl} etansulfonamidsalterInfo
- Publication number
- NO20084353L NO20084353L NO20084353A NO20084353A NO20084353L NO 20084353 L NO20084353 L NO 20084353L NO 20084353 A NO20084353 A NO 20084353A NO 20084353 A NO20084353 A NO 20084353A NO 20084353 L NO20084353 L NO 20084353L
- Authority
- NO
- Norway
- Prior art keywords
- acid salt
- difluorocyclohexyl
- ethanesulfonamide
- benzimidazol
- butyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78532606P | 2006-03-23 | 2006-03-23 | |
PCT/SE2007/000281 WO2007108754A1 (en) | 2006-03-23 | 2007-03-22 | Crystalline forms of n- {2-tert -butyl -1- [ (4,4- dif luorocyclohexyl) methyl] -lh-benzimidazol-5- yl}ethanesulfonamide salts |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20084353L true NO20084353L (no) | 2008-10-16 |
Family
ID=38522716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084353A NO20084353L (no) | 2006-03-23 | 2008-10-16 | Krystallinske former av N-{2-tert-butyl-1-[(4,4-difluorcykloheksyl)metyl]-1H-benzimidazol-5-yl} etansulfonamidsalter |
Country Status (18)
Country | Link |
---|---|
US (2) | US7566788B2 (ru) |
EP (1) | EP2001856A4 (ru) |
JP (1) | JP2009530373A (ru) |
KR (1) | KR20080105098A (ru) |
CN (1) | CN101454293A (ru) |
AR (1) | AR060065A1 (ru) |
AU (1) | AU2007227811A1 (ru) |
BR (1) | BRPI0709631A2 (ru) |
CA (1) | CA2648829A1 (ru) |
EC (1) | ECSP088714A (ru) |
IL (1) | IL193671A0 (ru) |
MX (1) | MX2008012015A (ru) |
NO (1) | NO20084353L (ru) |
RU (1) | RU2008136556A (ru) |
TW (1) | TW200745049A (ru) |
UY (1) | UY30232A1 (ru) |
WO (1) | WO2007108754A1 (ru) |
ZA (1) | ZA200807598B (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0302573D0 (sv) | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
BRPI0515897A (pt) * | 2004-09-24 | 2008-08-12 | Astrazeneca Ab | composto, uso do mesmo, composição farmacêutica, e, método para a terapia de dor em um animal de sangue quente, e para a preparação de um composto |
TW200808769A (en) * | 2006-04-18 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
US20110086853A1 (en) * | 2009-10-08 | 2011-04-14 | William Brown | Therapeutic Compounds |
CN101758337B (zh) | 2009-12-03 | 2012-02-15 | 湖南阿斯达生化科技有限公司 | 一种助焊剂用非卤素活性剂 |
GB202019335D0 (en) * | 2020-12-09 | 2021-01-20 | Artelo Biosciences Ltd | Pharmaceutical compositions |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1604908A (en) | 1965-06-24 | 1971-05-15 | Substd benzimidazoles - with anthelmintic,fungicidal activity and some with antiviral and antibacterial activity | |
FR5354M (ru) | 1965-09-10 | 1967-09-11 | ||
US5387600A (en) | 1992-07-30 | 1995-02-07 | Fuji Photo Film Co., Ltd. | Treating arteriosclerosis using benzimidazole compositions |
DE4237617A1 (de) | 1992-11-06 | 1994-05-11 | Bayer Ag | Verwendung von substituierten Benzimidazolen |
DE4237597A1 (de) | 1992-11-06 | 1994-05-11 | Bayer Ag | Substituierte Benzimidazole |
DE4237557A1 (de) | 1992-11-06 | 1994-05-11 | Bayer Ag | Substituierte Benzimidazole |
EP0882718B1 (en) | 1995-12-28 | 2005-08-31 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
US6348032B1 (en) | 1998-11-23 | 2002-02-19 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with benzimidazole derivatives |
WO2001012600A1 (en) | 1999-08-12 | 2001-02-22 | Cor Therapeutics, Inc. | INHIBITORS OF FACTOR Xa |
RU2002110295A (ru) | 1999-09-17 | 2003-12-10 | Милленниум Фармасьютикалс, Инк. (Us) | Ингибиторы фактора Ха |
US6720317B1 (en) | 1999-09-17 | 2004-04-13 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
US6632815B2 (en) | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
US7115645B2 (en) | 2000-01-14 | 2006-10-03 | Schering Aktiengesellschaft | 1,2 diarylbenzimidazoles and their pharmaceutical use |
EE05515B1 (et) | 2000-01-14 | 2012-02-15 | Schering@Aktiengesellschaft | 1 2 diarlbensimidasoolid mikrogliia aktivatsiooniga seotud haiguste raviks |
WO2001064642A2 (en) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
WO2002000651A2 (en) | 2000-06-27 | 2002-01-03 | Bristol-Myers Squibb Pharma Company | Factor xa inhibitors |
AU2002221239A1 (en) | 2000-12-07 | 2002-06-18 | Astrazeneca Ab | Therapeutic benzimidazole compounds |
SE0101387D0 (sv) | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | Novel compounds |
EP1403255A4 (en) | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | INHIBITORS OF RHO KINASE |
AR043633A1 (es) | 2003-03-20 | 2005-08-03 | Schering Corp | Ligandos de receptores de canabinoides |
SE0301699D0 (sv) | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
SE0301701D0 (sv) | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
WO2005007625A2 (en) | 2003-07-14 | 2005-01-27 | The University Of Tennessee Research Foundation | Heterocyclic amides with anti-tuberculosis activity |
WO2005021547A2 (en) * | 2003-08-28 | 2005-03-10 | Pharmaxis Pty Ltd. | Heterocyclic cannabinoid cb2 receptor antagonists |
SE0302571D0 (sv) | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
SE0302573D0 (sv) * | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
SE0302572D0 (sv) | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
SE0302570D0 (sv) | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
US20060035884A1 (en) | 2004-05-20 | 2006-02-16 | Elan Pharmaceuticals, Inc. | N-cyclic sulfonamido inhibitors of gamma secretase |
WO2006009876A2 (en) | 2004-06-17 | 2006-01-26 | Cengent Therapeutics, Inc. | Trisubstituted nitrogen modulators of tyrosine phosphatases |
PT1773768T (pt) | 2004-07-30 | 2018-11-30 | Exelixis Inc | Derivados de pirrol como agentes farmacêuticos |
US20060052421A1 (en) | 2004-09-09 | 2006-03-09 | Eastman Kodak Company | Conjugation agent |
JP2008514595A (ja) | 2004-09-24 | 2008-05-08 | アストラゼネカ・アクチエボラーグ | 化合物、それを含有する組成物、その製造及びその使用ii |
WO2006033628A1 (en) | 2004-09-24 | 2006-03-30 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
WO2006033627A1 (en) | 2004-09-24 | 2006-03-30 | Astrazeneca Ab | Compounds, compositions containing them, preparation thereof and uses thereof iiii |
AU2005287426A1 (en) | 2004-09-24 | 2006-03-30 | Astrazeneca Ab | Compounds, compositions containing them, preparation thereof and uses thereof III |
BRPI0515897A (pt) * | 2004-09-24 | 2008-08-12 | Astrazeneca Ab | composto, uso do mesmo, composição farmacêutica, e, método para a terapia de dor em um animal de sangue quente, e para a preparação de um composto |
JP2008514594A (ja) | 2004-09-24 | 2008-05-08 | アストラゼネカ・アクチエボラーグ | ベンゾイミダゾール誘導体及びカンナビノイド受容体リガンドとしてのその使用i |
CA2581232C (en) * | 2004-09-24 | 2015-04-07 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
EP1797075A1 (en) | 2004-09-24 | 2007-06-20 | AstraZeneca AB | Benzimidazole derivatives and their use as cannabinoid receptor ligands |
DE602005011844D1 (de) | 2004-11-02 | 2009-01-29 | Pfizer | Sulfonylbenzimidazolderivate |
WO2006078941A2 (en) | 2005-01-20 | 2006-07-27 | Sirtris Pharmaceuticals, Inc. | Novel sirtuin activating compounds and methods of use thereof |
-
2007
- 2007-03-20 TW TW096109540A patent/TW200745049A/zh unknown
- 2007-03-22 AR ARP070101183A patent/AR060065A1/es unknown
- 2007-03-22 JP JP2009501381A patent/JP2009530373A/ja active Pending
- 2007-03-22 AU AU2007227811A patent/AU2007227811A1/en not_active Abandoned
- 2007-03-22 EP EP07716083A patent/EP2001856A4/en not_active Withdrawn
- 2007-03-22 KR KR1020087023039A patent/KR20080105098A/ko not_active Application Discontinuation
- 2007-03-22 US US11/689,864 patent/US7566788B2/en not_active Expired - Fee Related
- 2007-03-22 WO PCT/SE2007/000281 patent/WO2007108754A1/en active Application Filing
- 2007-03-22 CN CNA2007800189539A patent/CN101454293A/zh active Pending
- 2007-03-22 MX MX2008012015A patent/MX2008012015A/es not_active Application Discontinuation
- 2007-03-22 CA CA002648829A patent/CA2648829A1/en not_active Abandoned
- 2007-03-22 UY UY30232A patent/UY30232A1/es unknown
- 2007-03-22 BR BRPI0709631-3A patent/BRPI0709631A2/pt not_active Application Discontinuation
- 2007-03-22 RU RU2008136556/04A patent/RU2008136556A/ru not_active Application Discontinuation
-
2008
- 2008-08-25 IL IL193671A patent/IL193671A0/en unknown
- 2008-09-03 ZA ZA200807598A patent/ZA200807598B/xx unknown
- 2008-09-03 EC EC2008008714A patent/ECSP088714A/es unknown
- 2008-10-16 NO NO20084353A patent/NO20084353L/no not_active Application Discontinuation
-
2009
- 2009-07-23 US US12/508,112 patent/US20100022610A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2007108754A1 (en) | 2007-09-27 |
AR060065A1 (es) | 2008-05-21 |
MX2008012015A (es) | 2008-10-01 |
US7566788B2 (en) | 2009-07-28 |
UY30232A1 (es) | 2007-10-31 |
EP2001856A4 (en) | 2011-02-16 |
TW200745049A (en) | 2007-12-16 |
AU2007227811A1 (en) | 2007-09-27 |
CN101454293A (zh) | 2009-06-10 |
US20100022610A1 (en) | 2010-01-28 |
KR20080105098A (ko) | 2008-12-03 |
BRPI0709631A2 (pt) | 2011-07-19 |
CA2648829A1 (en) | 2007-09-27 |
EP2001856A1 (en) | 2008-12-17 |
US20070225346A1 (en) | 2007-09-27 |
JP2009530373A (ja) | 2009-08-27 |
ECSP088714A (es) | 2008-10-31 |
IL193671A0 (en) | 2009-05-04 |
RU2008136556A (ru) | 2010-04-27 |
ZA200807598B (en) | 2010-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20084353L (no) | Krystallinske former av N-{2-tert-butyl-1-[(4,4-difluorcykloheksyl)metyl]-1H-benzimidazol-5-yl} etansulfonamidsalter | |
CR20170115A (es) | Compuestos y métodos inhibidores de jak de pirazolopirimidina | |
CO6220935A2 (es) | Derivados de 1,2,4-triazol como moduladores de mglur5 | |
CO5700780A2 (es) | Derivados de quinolina como inhibidores, selectivos, de de fosfodiesterasa pde 4b | |
PE20100263A1 (es) | Derivados condensados de imidazol para la inhibicion de sintasa de aldosterona y aromatasa | |
NO20092692L (no) | MAPK/ERK kinaseinhibitorer | |
AR047456A1 (es) | Derivados de amidas, procesos para su preparacion y uso como insecticidas | |
MY153621A (en) | Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity | |
CR20110049A (es) | Derivados de benzazepina y su uso como antagonistas de histamina h3 | |
CO6140060A2 (es) | Derivados de aminocicloalquil 1,2,4-triazol como moduladores de mglur5 | |
NO20082090L (no) | Pyridopyrimidinoninhibitorer av P13K alfa | |
ES2422298T3 (es) | Cetales de cetometionina y sus derivados | |
NO20054710D0 (no) | Immunmodulerende heterosykliske forbindelser | |
WO2011141933A3 (en) | Process for preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid and its pharmaceutically acceptable salts | |
CR20110369A (es) | Derivados de quinazolinona útiles como antagonistas de vanilloides | |
ES2421896T3 (es) | Compuestos de aril-(imidazol)-metil-fenilo sustituidos como moduladores selectivos de los subtipos de receptores adrenérgicos alfa 2B y/o alfa 2C | |
CL2021000031A1 (es) | Compuestos heterocíclicos antihelmínticos | |
AR118278A2 (es) | Compuestos derivados de piperazinil-alquil-4(3h)-quinazolinonas | |
RS54413B1 (en) | [4- (5-AMINOMETHYL-2-FLUORO-PHENYL) -PIPERIDIN-1-IL] - [7-FLUORO-1- (2-METHOXY-ETHYL) -4TRIFLUOROMETOXY-1H-INDOL-3-IL] METHANONE AS INHIBITOR MASTOCYT TRIPTASES | |
BRPI0910761A2 (pt) | compostos tendo atividade antagonista de receptores npy y5 e composições farmacêuticas compreendendo os mesmos | |
NO20060079L (no) | 6-(1,1-Difluoralkyl)-4-Aminopikolinater og deres anvendelse som Herbicider | |
AR066710A1 (es) | Derivados de espirociclopropilpiperidina | |
NO20063111L (no) | Fremgangsmate for fremstilling av tiazolpyrimidiner | |
NO20051009L (no) | Syntese av indoliziner | |
PE20081683A1 (es) | Nuevos derivados de sulfonamida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |